Diseases · Entity Annotation Prototype (beta)

3articles mentioning diseases

9disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: DORIS ×

DORIS

This disease is selected. Its supporting articles are shown below.

DORIS3

Articles mentioning DORIS

3 articles · page 1 of 1

PO:11:300 Evaluating DORIS remission attainment with anifrolumab in immunosuppressant- and biologic-naïve patients with SLE: design of SUNFLOWER, a phase 3b prospective study

lupusscimed · abstract · 2026-03-01 · 7 matching annotations

94.8%

SLE DORIS anifrolumab AstraZeneca Avalere Health SUNFLOWER

…llowing subcutaneous anifrolumab initiation among patients with SLE who are naïve to conventional immunosuppressants/other biologic…

Belimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trials

rmdopen · abstract · 2026-07-03 · 1 matching annotations

78.9%

SLE systemic lupus erythematosus DORIS belimumab BLISS-SC EMBRACE BLISS-76 BLISS-52

…GC-DORIS and non-GC-LLDAS attainment rates (calculated based on SLE Disease Activity Index 2000 and Physician’s Global Assessment o…

Efficacy and safety of anifrolumab in patients with systemic lupus erythematosus without prior immunosuppressant use: post hoc analysis of phase 3 TULIP-1 and TULIP-2 trials

lupusscimed · abstract · 2026-04-08 · 1 matching annotations

79.0%

systemic lupus erythematosus SLE DORIS Anifrolumab

…Objective Although current treatment recommendations for systemic lupus erythematosus (SLE) provide the option for biologic agents without prior fail…